Literature DB >> 11958327

Balloon angioplasty and stent implantation induce a vascular inflammatory reaction.

Martin Schillinger1, Markus Exner, Wolfgang Mlekusch, Markus Haumer, Ramazanali Ahmadi, Helmut Rumpold, Oswald Wagner, Erich Minar.   

Abstract

PURPOSE: To investigate whether peripheral balloon angioplasty with and without stent implantation independently causes an inflammatory vascular response measured by serum acute-phase reactants.
METHODS: This was a prospective cohort study enrolled 388 consecutive patients (218 men; median age 70 years, interquartile range 59-76) with peripheral artery disease undergoing balloon angioplasty (n = 187), stent implantation (n = 140), and diagnostic angiography (control group, n = 61). C-reactive protein (CRP) measured by standard and high-sensitivity assays, serum amyloid A (SAA), fibrinogen, and white blood cell (WBC) count were obtained at baseline and at 8, 24, and 48 hours postintervention. Polynomial logistic regression analysis was used to assess the independent association of acute-phase reactants and the interventional group.
RESULTS: CRP levels measured by both standard and the high-sensitivity assays significantly increased after balloon angioplasty (standard CRP, p = 0.02; high-sensitivity CRP, p = 0.02) and stent implantation (standard CRP, p = 0.004; high-sensitivity CRP, p = 0.008) compared to the control group adjusting for age, sex, duration of fluoroscopy, volume of contrast, and periprocedural complications. SAA values differed only between the stent group and controls (p = 0.05). Fibrinogen and WBCs were not different among the 3 interventional groups.
CONCLUSIONS: Balloon injury and stent implantation induce a vascular inflammatory response at the dilated vessel segment measurable by serum acute-phase parameters. The standard CRP assay is adequate to quantify acute-phase response in these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958327     DOI: 10.1177/152660280200900111

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  14 in total

Review 1.  Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2015-11-01

2.  Comparison of effects of statin use on mortality in patients with peripheral arterial disease with versus without elevated C-reactive protein and d-dimer levels.

Authors:  Himabindu Vidula; Lu Tian; Kiang Liu; Michael H Criqui; Luigi Ferrucci; Jack M Guralnik; David Green; Paul Ridker; Mary M McDermott
Journal:  Am J Cardiol       Date:  2010-03-19       Impact factor: 2.778

3.  Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.

Authors:  Christopher D Owens; Paul M Ridker; Michael Belkin; Allen D Hamdan; Frank Pomposelli; Frank Logerfo; Mark A Creager; Michael S Conte
Journal:  J Vasc Surg       Date:  2006-11-21       Impact factor: 4.268

4.  A predictive multiscale model of in-stent restenosis in femoral arteries: linking haemodynamics and gene expression with an agent-based model of cellular dynamics.

Authors:  Anna Corti; Monika Colombo; Jared M Rozowsky; Stefano Casarin; Yong He; Dario Carbonaro; Francesco Migliavacca; Jose F Rodriguez Matas; Scott A Berceli; Claudio Chiastra
Journal:  J R Soc Interface       Date:  2022-03-30       Impact factor: 4.118

5.  Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.

Authors:  Izuagie Attairu Ikhapoh; Christopher J Pelham; Devendra K Agrawal
Journal:  Differentiation       Date:  2015-04-23       Impact factor: 3.880

Review 6.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

Review 7.  [Medicinal therapy for interventional surgery of the peripheral vascular system].

Authors:  J Tacke; E Lindhoff-Last
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

8.  Current Status of Drug-Eluting Stents and Drug-Eluting Balloons for the Superficial Femoral Artery.

Authors:  Joy P Walker; Christopher D Owens
Journal:  Curr Surg Rep       Date:  2013-06-01

Review 9.  Restenosis after percutaneous angioplasty: the role of vascular inflammation.

Authors:  Martin Schillinger; Erich Minar
Journal:  Vasc Health Risk Manag       Date:  2005

Review 10.  Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stent.

Authors:  Jason Litsky; Arijit Chanda; Erik Stilp; Alexandra Lansky; Carlos Mena
Journal:  Med Devices (Auckl)       Date:  2014-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.